The Access Consortium is a collaborative initiative between five Health Authorities: Australia’s Therapeutic Goods Administration (TGA), Health Canada (HC), Singapore’s Health Sciences Authority (HSA), the Swiss Agency for Therapeutic Products (Swissmedic) and the Medicines and Healthcare products Regulatory Agency (MHRA) of the UK. It intends to build synergies and maximize international cooperation to ensure patients’ timely access to safe therapeutic products in the member countries.
The Access Consortium consist of different working groups:
Asphalion can provide support throughout the whole process in a variety of activities, discover how!
Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts.
We will be happy to assist you!